Suppr超能文献

三种无烟气烟草依赖测量方法的比较。

A comparison of three smokeless tobacco dependence measures.

机构信息

Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.

出版信息

Addict Behav. 2012 Nov;37(11):1271-7. doi: 10.1016/j.addbeh.2012.06.011. Epub 2012 Jun 21.

Abstract

Smokeless tobacco (ST) use is associated with tobacco dependence and long-term adverse health consequences. Clinical and research tools that can accurately assess ST dependence are needed to improve research and treatment of ST users. Measures of ST dependence have been developed to address this need. We used data from a study evaluating the effectiveness of bupropion sustained release for the treatment of ST use (N=225) to compare the Fagerström Tolerance Questionnaire for Smokeless Tobacco (FTQ-ST) users, the Severson Smokeless Tobacco Dependency Scale (SSTDS), and the Glover-Nilsson Smokeless Tobacco Behavioral Questionnaire (GN-STBQ). We observed that despite the intention of the scale: (1) all scales were significantly correlated with ST cans consumed per week; (2) the FTQ-ST was significantly correlated with serum nicotine and cotinine concentrations and craving; (3) the GN-STBQ and SSTDS were significantly associated with both craving and withdrawal; and (4) none of the scales were significantly associated with ST abstinence. When all of the scales were entered simultaneously in a multivariable analysis, the SSTDS was the only scale independently associated with withdrawal and craving. As when used with cigarette smokers, the FTQ-ST appeared to measure the construct of physical dependence. The GN-STBQ and SSTDS, designed to measure broader constructs of dependence, were found to predict both withdrawal and craving which may be advantageous in clinical settings. The GN-STBQ and the FTQ-ST did not contribute significantly to the prediction of withdrawal and craving beyond what was accomplished using the SSTDS. The use of the scales is discussed in terms of clinical usefulness and how each scale might assess differing aspects of tobacco dependence.

摘要

无烟烟草(ST)的使用与烟草依赖和长期不良健康后果有关。需要能够准确评估 ST 依赖的临床和研究工具,以改善 ST 用户的研究和治疗。已经开发了衡量 ST 依赖的措施来满足这一需求。我们使用了一项评估丁胺苯丙酮缓释剂治疗 ST 使用效果的研究(N=225)的数据,比较了无烟烟草 Fagerström 耐受性问卷(FTQ-ST)、塞弗森无烟烟草依赖量表(SSTDS)和格洛弗-尼尔森无烟烟草行为问卷(GN-STBQ)。我们观察到,尽管这些量表的目的是:(1)所有量表都与每周消耗的 ST 罐数显著相关;(2)FTQ-ST 与血清尼古丁和可替宁浓度和渴望显著相关;(3)GN-STBQ 和 SSTDS 与渴望和戒断都显著相关;(4)没有一个量表与 ST 戒断显著相关。当所有量表同时进入多变量分析时,SSTDS 是唯一与戒断和渴望相关的量表。与用于吸烟人群时一样,FTQ-ST 似乎测量了身体依赖的结构。GN-STBQ 和 SSTDS 旨在测量更广泛的依赖结构,被发现可以预测戒断和渴望,这在临床环境中可能是有利的。GN-STBQ 和 FTQ-ST 对戒断和渴望的预测并没有超过 SSTDS 的贡献。讨论了这些量表的临床用途,以及每个量表如何评估烟草依赖的不同方面。

相似文献

1
A comparison of three smokeless tobacco dependence measures.
Addict Behav. 2012 Nov;37(11):1271-7. doi: 10.1016/j.addbeh.2012.06.011. Epub 2012 Jun 21.
2
Evaluating the Psychometric Properties of the Severson 7-Item Smokeless Tobacco Dependence Scale (SSTDS).
Nicotine Tob Res. 2021 Jun 8;23(7):1224-1229. doi: 10.1093/ntr/ntaa269.
3
Measuring nicotine dependence among smokeless tobacco users.
Addict Behav. 2006 Sep;31(9):1511-21. doi: 10.1016/j.addbeh.2005.11.005. Epub 2006 Jan 4.
4
A multiple motive/multi-dimensional approach to measure smokeless tobacco dependence.
Addict Behav. 2014 Mar;39(3):622-9. doi: 10.1016/j.addbeh.2013.11.016. Epub 2013 Nov 27.
5
A review of the validity and reliability of smokeless tobacco dependence measures.
Addict Behav. 2012 Apr;37(4):361-6. doi: 10.1016/j.addbeh.2011.12.003. Epub 2011 Dec 20.
6
Psychometric properties of smokeless tobacco dependence measures: A COSMIN systematic review.
J Subst Use Addict Treat. 2023 Apr;147:208978. doi: 10.1016/j.josat.2023.208978. Epub 2023 Feb 13.
7
Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.
Nicotine Tob Res. 2002 Aug;4(3):267-74. doi: 10.1080/14622200210153821.
8
Comparative effectiveness of the nicotine lozenge and tobacco-free snuff for smokeless tobacco reduction.
Addict Behav. 2013 May;38(5):2140-5. doi: 10.1016/j.addbeh.2013.01.023. Epub 2013 Feb 4.
9
The Fagerström Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST).
Addict Behav. 2006 Sep;31(9):1716-21. doi: 10.1016/j.addbeh.2005.12.015. Epub 2006 Jan 31.
10
Bupropion SR for the treatment of smokeless tobacco use.
Drug Alcohol Depend. 2007 Sep 6;90(1):56-63. doi: 10.1016/j.drugalcdep.2007.02.008. Epub 2007 Mar 13.

引用本文的文献

1
Interventions for smokeless tobacco use cessation.
Cochrane Database Syst Rev. 2025 Apr 15;4(4):CD015314. doi: 10.1002/14651858.CD015314.pub2.
3
Psychometric properties of Fagerström Tolerance Questionnaire among Turkmen Nass (Naswar) users.
Addict Sci Clin Pract. 2023 May 23;18(1):32. doi: 10.1186/s13722-023-00390-1.
4
Development and psychometric evaluation of the Khaini Smokeless Tobacco Dependence Scale.
Tob Induc Dis. 2023 Mar 15;21:40. doi: 10.18332/tid/160073. eCollection 2023.
5
[Study of correlation between different scales that measure smoking dependence].
Aten Primaria. 2023 Mar;55(3):102581. doi: 10.1016/j.aprim.2023.102581. Epub 2023 Feb 14.
7
Baseline characteristics of American Indian smokeless tobacco users participating in two pilot cessation studies.
J Community Health. 2020 Aug;45(4):812-819. doi: 10.1007/s10900-020-00797-w.
8
One-Time Education Sessions to Help American Indian Smokeless Tobacco Users Quit.
J Community Health. 2020 Jun;45(3):526-533. doi: 10.1007/s10900-019-00771-1.
9
The state of smokeless tobacco cessation in a context lacking cessation services: Evidence from Ethiopia.
Tob Induc Dis. 2019 Oct 29;17:74. doi: 10.18332/tid/112668. eCollection 2019.

本文引用的文献

1
The assessment of tobacco dependence in young users of smokeless tobacco.
Tob Control. 2012 Sep;21(5):471-6. doi: 10.1136/tc.2011.043810. Epub 2011 Jun 28.
2
Development of the Brief Wisconsin Inventory of Smoking Dependence Motives.
Nicotine Tob Res. 2010 May;12(5):489-99. doi: 10.1093/ntr/ntq032. Epub 2010 Mar 15.
3
Effects of abstinence from tobacco: valid symptoms and time course.
Nicotine Tob Res. 2007 Mar;9(3):315-27. doi: 10.1080/14622200701188919.
4
Self-help cessation programs for smokeless tobacco users: long-term follow-up of a randomized trial.
Nicotine Tob Res. 2007 Feb;9(2):281-9. doi: 10.1080/14622200601080281.
5
Bupropion SR for the treatment of smokeless tobacco use.
Drug Alcohol Depend. 2007 Sep 6;90(1):56-63. doi: 10.1016/j.drugalcdep.2007.02.008. Epub 2007 Mar 13.
6
National Institutes of Health State-of-the-Science conference statement: tobacco use: prevention, cessation, and control.
Ann Intern Med. 2006 Dec 5;145(11):839-44. doi: 10.7326/0003-4819-145-11-200612050-00141. Epub 2006 Sep 5.
7
The Fagerström Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST).
Addict Behav. 2006 Sep;31(9):1716-21. doi: 10.1016/j.addbeh.2005.12.015. Epub 2006 Jan 31.
8
Measuring nicotine dependence among smokeless tobacco users.
Addict Behav. 2006 Sep;31(9):1511-21. doi: 10.1016/j.addbeh.2005.11.005. Epub 2006 Jan 4.
9
Developmental history of the Glover-Nilsson smoking behavioral questionnaire.
Am J Health Behav. 2005 Sep-Oct;29(5):443-55. doi: 10.5555/ajhb.2005.29.5.443.
10
Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States).
Cancer Causes Control. 2005 May;16(4):347-58. doi: 10.1007/s10552-004-5519-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验